Today: 30 June 2026
Intuit stock tumbles 11% then slips again premarket as AI jitters rattle software names

Intuit stock tumbles 11% then slips again premarket as AI jitters rattle software names

New York, Feb 4, 2026, 07:29 (EST) — Premarket

  • Intuit shares edged down about 0.7% in premarket, after plummeting 10.9% on Tuesday.
  • Software and data stocks plunged sharply amid fresh worries over AI-driven disruption.
  • Traders are zeroing in on Intuit’s earnings call scheduled for Feb. 26, looking for clues and guidance ahead of tax season.

Intuit Inc shares dipped 0.7% to $431.03 in premarket trading Wednesday, after tumbling 10.9% at Tuesday’s close. The premarket session takes place in the brief period before the Nasdaq opens at 9:30 a.m. ET.

Intuit’s recent slide has turned into a sharp indicator of risk appetite in the software sector, with investors offloading cloud stocks over several sessions. The software and services index has fallen for five days in a row, shedding more than 12%, Reuters reported. Market watchers are also eyeing ADP’s private payrolls report due at 8:15 a.m. ET, alongside Alphabet’s earnings release after the bell.

The sell-off picked up steam Tuesday after AI developer Anthropic rolled out plug-ins for its Claude Cowork agent, automating tasks in legal, sales, marketing, and data analysis. Investors, spooked by AI’s threat to pricing power in established software firms, pulled back sharply. “Sometimes the market just shoots first and asks questions later,” said Mike Archibald, a portfolio manager at AGF Investments in Toronto, as the S&P 500 slipped 0.84% and the Nasdaq dropped 1.43%. Reuters

Intuit is set to unveil its fiscal second-quarter results on Feb. 26, with a conference call scheduled for 4:30 p.m. EST, according to the company’s investor calendar. This event is a crucial moment for Intuit shares, as investors look for updates on the TurboTax filing season and small-business demand tied to QuickBooks.

Oppenheimer held firm on its Outperform rating for Intuit but slashed the price target to $696 from $868 on Tuesday, a note summary on GuruFocus shows. Keep in mind, price targets are projections — not guarantees.

Intuit is expanding payment options in QuickBooks with a new multi-year pact announced Monday. Affirm will become the exclusive pay-over-time choice within QuickBooks Payments. The feature is set to launch “in the coming months” for eligible U.S. businesses. “We are giving businesses a powerful new way to increase conversion and improve cash flow,” said Intuit executive David Hahn. Intuit Inc.

The selloff isn’t just a one-off; it’s shaking the entire sector. Toby Ogg at JP Morgan said software stocks are being “sentenced before trial.” Over at Quilter Cheviot, Ben Barringer pointed out that investors are “choosing to shun the software market altogether,” as skepticism about AI agents’ capabilities grows. Intuit dipped 0.6% in U.S. premarket, Reuters reported in its wider sector roundup. Reuters

Nvidia CEO Jensen Huang challenged the idea that AI will upend software tools during a Cisco event in San Francisco, calling that view “illogical.” He argued that recent AI breakthroughs are enhancements that build on current tools rather than replace them wholesale. Reuters

Traders are set to track whether Intuit shares maintain their footing post-open as the software sector digests fresh AI developments. Attention then turns to Feb. 26, when Intuit releases its earnings and outlook during the peak of tax season.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held
Previous Story

Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held

Micron stock sinks nearly 10% as AI jitters hit chipmakers again
Next Story

Micron stock sinks nearly 10% as AI jitters hit chipmakers again

Go toTop